Showing results (21-30 of 223) with videos related to
Sort By:
Pageof 23
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 11, 1998
Cytochrome P4502D6 catalyzes the O-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamineR S Obach, J Pablo, D C MashJournal of Neural Transmission (Vienna, Austria : 1996)|November 25, 2003
Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brainM J Hurley, D C Mash, P JennerThe European Journal of Neuroscience|November 19, 2003
Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCRMichael J Hurley, Deborah C Mash, Peter JennerNeuroscience Letters|August 30, 2000
Adenosine A(2A) receptor mRNA expression in Parkinson's diseaseM J Hurley, D C Mash, P JennerBrain Research. Brain Research Protocols|August 14, 1999
Semi-quantitative reverse-transcriptase polymerase chain reaction: an approach for the measurement of target gene expression in human brainL Chen, D M Segal, D C MashBrain Research. Molecular Brain Research|March 14, 2001
Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson's diseaseM J Hurley, D C Mash, P JennerMolecular Psychiatry|November 1, 2006
Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victimsN Tannu, D C Mash, S E HembyAnnals of Neurology|March 1, 1991
Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapiesD D Flynn, D A Weinstein, D C MashJournal of Neuroscience Methods|March 15, 2005
Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusersDeborah C Mash, Qinjie Ouyang, Yujing Qin, et al.Acta Neurologica Scandinavica|May 7, 2005
Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?S Papapetropoulos, A Lieberman, J Gonzalez, et al.Pageof 23